|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.99 AUD | +0.67% |
|
-1.06% | -6.31% |
| Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
| Mar. 14 | Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 | MT |
•
•
•
•
•
•
•
•
•
•
•
•
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer
Clinuvel Pharmaceuticals Limited published this content on 24 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 February 2021 23:47:06 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.31% | 487M | |
| -2.86% | 87.31B | |
| +2.63% | 40.86B | |
| -21.44% | 29.36B | |
| +58.56% | 24.49B | |
| -14.37% | 17.31B | |
| -18.67% | 11.62B | |
| -15.61% | 11.31B | |
| -44.02% | 11.26B | |
| +5.17% | 8.31B |
CLINUVEL PHARMACEUTICALS LIMITED 
